Providing innovative and affordable medicines
for all patients




Ever since the inception, Henlius has established a quality management system in line with international quality standards, which covers the entire product life cycle, from research and development to material management, product manufacturing, quality control, product supply management and particularly, product post-marketing surveillance. The system lays the foundation to commercialise our products in multiple countries and regions.

Xuhui Manufacturing Facility has passed on-site inspections and / or audits conducted by the NMPA, EMA, the European United (EU) QP and international commercial partners such as Accord Healthcare and Cipla, with the production capacity for the current clinical and commercial stage. The drug substance (DS) line and drug product (DP) line for 漢曲優® (HLX02, trastuzumab injection, Zercepac® in the EU) have successfully passed China GMP compliance on-site inspection and EU GMP on-site inspection.Henlius received two EU GMP Certificates (Certificate of GMP Compliance of a Manufacturer) from Poland’s Chief Pharmaceutical Inspector. 

The Global Quality Operations department takes charge of the quality management system to ensure the realization of the standard and the execution of the system. The demonstrated commitment to quality management will distinguish Henlius in the PRC market, highlighting the Company's long-term dedications to providing patients worldwide with access to reliable and quality therapies. 




hg320挂赚钱宝网络卡 北京快三直播 浙江11选5最新版 幸运赛车冠军选号技巧 18日股票大盘下跌 山东11选5手机版下载 股票融资是好是坏 双色球开奖结果 福彩天津快乐十分 福建十一选五开奖结果前一遗漏 广西快3开奖号码 极速赛车技巧论坛 黑龙江36选7最新开奖结果 重庆农场平台下载 配资网 湖北11选5推荐预测 排列5预测最准十专家